The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis.


Karadag-Saygi E. , Akyuz G. , Bizargity P., Ay P.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, cilt.27, ss.1033-6, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 27 Konu: 12
  • Basım Tarihi: 2011
  • Doi Numarası: 10.3109/09513590.2011.579657
  • Dergi Adı: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • Sayfa Sayıları: ss.1033-6

Özet

Background. To evaluate the effect of risedronate treatment on osteoprotegerin (OPG), C-terminal cross-linking telopeptide of type 1 collagen (CTX), osteocalcin (OC), and deoxypyridinoline (DPD).